Factors Associated with a Disposition-Based Indicator of Severe Injury Among Older Adults with Fall-Related Injuries: A Secondary Analysis of the 2023 Emergency Department-Based Injury In-Depth Surveillance
Abstract
Background/Objectives: Falls are a major cause of injury-related morbidity and mortality among older adults. This study aimed to examine factors associated with a disposition-based indicator of severe injury among older adults with fall-related injuries using data from the 2023 Emergency Department-based Injury In-depth Surveillance. Methods: This secondary analysis used data from the 2023 Emergency Department-based Injury In-depth Surveillance conducted by the Korea Disease Control and Prevention Agency. A total of 24,632 adults aged ≥65 years with fall-related injuries were included. The primary outcome was a disposition-based indicator of severe injury, defined as hospital admission, transfer to a higher-level hospital, or death. Multivariable logistic regression was performed, and sensitivity analyses were performed using alternative disposition-based outcomes, Revised Trauma Score (RTS)-based physiological severity, and the original four AVPU categories. Results: Of 24,632 participants, 9248 (37.5%) met the criteria for the primary outcome. Older age, falls from a height, outdoor injuries, emergency transportation, and impaired consciousness were associated with higher odds of the primary outcome, whereas alcohol use at the time of injury, stair-related falls, injuries in road or traffic areas or commercial or public facilities, sports or leisure activities, other activities, and nighttime injuries were associated with lower odds. Emergency transportation and impaired…
How strong is the evidence?
Evidence Hub reads this as a secondary / pooled analysis, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 24,632 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.